fb-post-fibro.jpg

Fibromyalgia 2016

Added by Ben12

Double Tree by Hilton Philadelphia Airport 4509 Island Ave Philadelphia, PA 19153, USA
Contact Event Organizer

Contact the Event Organizer

To inquire about this event, complete the form below to send a message to the event organizer.


International Conference on Fibromyalgia and Chronic Pain
June 15-16, 2016 Philadelphia, Pennsylvania, USA

We are glad to invite you all to the “International conference and Exhibition on Fibromyalgia and chronic pain’’ June15-16, 2016 Philadelphia, USA. Fibromyalgia 2016 !aims to gather leading educational scientists, researchers and research students to exchange & share their experiences and research results about all aspects of Fibromyalgia and Chronic Pain.

Theme: Recent trends, advancements and discoveries on Fibromyalgia and Chronic pain Fibromyalgia 2016.
The event offers a best platform with its well organized scientific program, symposiums, workshops, keynote lectures, plenary talks, panel discussions and poster sessions on latest research and technological developments in the arena as well as therapeutic aspects of Fibromyalgia and chronic Pain

Fibromyalgia and Chronic pain are the most common cause of serious disability and have a major but often unrecognized, impact on health and social services. There are 30 million people around the world living with a neurological condition which has a significant impact on their lives. Fibromyalgia is estimated to affect 2–8% of the population, with a female to male incidence ratio that is somewhere between 7:1 and 9:1.
The fibromyalgia drug market will experience minimal growth over the next decade, increasing from nearly $1.6 billion in 2010 to less than $1.8 billion in 2020 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan. Increasing number of patients with rheumatoid arthritis, and rise in R&D activities for drug discovery and development are some of the major factors driving the growth of rheumatoid arthritis therapeutics market. The market for disease-modifying Rheumatoid arthritis therapeutics is expected to increase from $56.6 billion in 2013 to $80.7 billion in 2020, at a Compound Annual Growth Rate (CAGR) of 5.2%.
For more information visit: Website: http://fibromyalgia.conferenceseries.com/

To book slot, Sponsor or Exhibition Contact:
Ph: 1800 216 6499 , 702 508 5202.
fibromyalgia@omicsgroup.com;fibromyalgia@conferencesseries.com; fibromyalgia@conferencess.net.

Leave a Comment

Leave a Reply

Your email address will not be published. (* denotes required field)

*

Vantage Theme – Powered by WordPress.
Skip to toolbar